GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Atara Biotherapeutics stock price on Friday moving 10.51% between high and low
(Updated on Apr 19, 2024)

Sell candidate since Apr 11, 2024 Loss -7.27% PDF

The Atara Biotherapeutics stock price fell by -4.44% on the last day (Friday, 19th Apr 2024) from $0.692 to $0.661. During the last trading day the stock fluctuated 10.51% from a day low at $0.640 to a day high of $0.707. The price has fallen in 8 of the last 10 days and is down by -14.61% for this period. Volume has increased on the last day by 807 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $1.07 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.01% during the next 3 months and, with a 90% probability hold a price between $0.462 and $1.07 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRA Signals & Forecast

There are few to no technical positive signals at the moment. The Atara Biotherapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.693 and $0.703. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 02, 2024, and so far it has fallen -45.82%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Atara Biotherapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Atara Biotherapeutics stock

Atara Biotherapeutics finds support from accumulated volume at $0.630 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0673 between high and low, or 10.51%. For the last week, the stock has had daily average volatility of 9.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRA) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Atara Biotherapeutics to open at $0.670, and during the day (based on 14 day Average True Range), to move between $0.595 and $0.727, which gives a possible trading interval of +/-$0.0661 (+/-10.00%) up or down from last closing price. If Atara Biotherapeutics takes out the full calculated possible swing range there will be an estimated 20.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.630 (4.69%) than the resistance at $0.762 (15.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Atara Biotherapeutics stock A Buy?

Atara Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.383 Strong Sell Candidate Downgraded

Predicted Opening Price for Atara Biotherapeutics of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.670 ( 1.29%) $0.661

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.737 11.47 %
R2 0.711 7.58 %
R1 0.695 5.18 %
Current price: 0.661
Support S1 0.644 -2.60 %
S2 0.628 -5.01 %
S3 0.602 -8.90 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.83 24.95 %
R2 0.778 17.70 %
R1 0.762 15.20 %
Current price 0.661
Support S1 0.630 -4.69%
S2 0.621 -6.08%
S3 0.601 -9.06%

FAQ

What is the symbol for Atara Biotherapeutics Stock and on which exchange is it traded?
The symbol for Atara Biotherapeutics is ATRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Atara Biotherapeutics Stock?
Atara Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Atara Biotherapeutics Stock?
Atara Biotherapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Atara Biotherapeutics Stock.

What's the current price of Atara Biotherapeutics Stock?
As of the end of day on the 2024-04-19, the price of an Atara Biotherapeutics (ATRA) share was $0.661.

What is the 52-week high and low for Atara Biotherapeutics Stock?
The 52-week high for Atara Biotherapeutics Stock is $3.06 and the 52-week low is $0.199.

What is the market capitalization of Atara Biotherapeutics Stock?
As of the 2024-04-19, the market capitalization of Atara Biotherapeutics is 85.33M.

When is the next earnings date for Atara Biotherapeutics?
The upcoming earnings date for Atara Biotherapeutics is May 13, 2024.
Click to get the best stock tips daily for free!

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT